Dr. Maxime Barakat

Bausch Health Companies, Montreal, QC

Dr. Maxime Barakat is an accomplished medical professional with more than 20 years of experience in the pharmaceutical industry. He is currently the Head and Vice-president of International Medical and Clinical Affairs at Bausch Health Companies (BHC), a global pharmaceutical company, and Vice-president, Solta Medical Affairs.
Dr. Barakat received his Doctorate in Medicine (MD) from a medical institute in Ukraine in 1990. After moving to Canada in 1993, he passed the evaluation examination of the Medical Council of Canada and was granted his MD recognition.
Dr. Barakat continued his education and research, and in 2003, he received his Doctorate in Pharmacology (PhD) from the University of Montreal. In 2019, he completed an Executive MBA from the School of Sciences Management at UQAM in Montreal and the University of Paris Dauphine in Paris.
Dr. Barakat has held a variety of positions in the pharmaceutical industry, including Medical Director at Bristol-Myers Squibb, Manager and Associate Director of Market Access at Bristol-Myers Squibb, and Vice-president of Axiome Communications. He has also served as an invited speaker on drug development at the University of Montreal, Canada.
In his current role at Bausch Health, Dr. Barakat is responsible for leading the company's international medical and clinical affairs activities. He is also responsible with his international teams for developing and implementing the company's medical strategy.

2:25 PM - 2:55 PM

SAT Apr 20

Behind the 2024 Acne Guidelines: Takeaways and Recommended Implementation Strategies

The presentation will take the form of three “mini-modules” of approximately eight minutes each, followed by six minutes of questions from delegates. The modules are:

  1. Key takeaways from the recent AAD acne guidelines;
  2. Current thinking and anticipated directions of the forthcoming Canadian Acne guidelines; and,
  3. “What’s Next in Acne Therapy”: new therapies and emerging considerations for patient care.

Learning Objectives:

  1. To educate dermatologists and healthcare professionals regarding the 2024 Acne
  2. Vulgaris Guidelines, and to discuss implementing these guidelines in the Canadian healthcare setting

Bausch Health in collaboration with The Chronicle Information Resources Open Presentation.